![Jeffrey Bacha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Bacha
Président chez
RAKOVINA THERAPEUTICS INC.
Fortune : 34 755 $ au 31/08/2026
Profil
Jeffrey A. Bacha was the founder of Kintara Therapeutics, Inc., founded in 2009, where the title held was Director in 2018.
Mr. Bacha is the founder of Del Mar Pharmaceuticals (BC) Ltd., founded in 2010, holding the titles of President, Chief Executive Officer & Director since 2012.
Mr. Bacha is the founder of Edison Oncology Holding Corp., founded in 2018, serving as Chief Executive Officer & Director starting in 2025.
Current jobs include CEO, Chief Financial Officer & Director at NewGen Therapeutics, Inc.; Non-Executive Chairman at Rakovina Therapeutics, Inc. since 2026; Independent Director at AD4 Capital Corp.
since 2021; Director at Leukemia & Lymphoma Society Greater San Francisco Bay Area since 2018; and Member-Research Roundtable at National Brain Tumor Society, Inc. Former jobs include President & Chief Executive Officer at Inimex Pharmaceuticals, Inc. from 1999 to 2004; Chairman at Covenant House Vancouver; Independent Director at Sernova Biotherapeutics, Inc. from 2008 to 2022; Director at CalEthos, Inc. from 2008 to 2009; Founding Director at Urigen Holdings, Inc.; Director & Senior Manager at KPMG Health Ventures from 1995 to 1999; Chief Operating Officer & Executive Vice President at Clerac LLC from 2006 to 2009; Chief Financial Officer & VP-Corporate Development at XBiotech USA, Inc.; Chief Operating Officer & EVP-Corporate Affairs at Clera Inc. from 2005 to 2009; and Vice President-Corporate Development at EACOM Timber Corp.
in 2002.
Education includes an undergraduate degree from the University of California San Diego in 1991 and an MBA from Goizueta Business School-Emory in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/06/2025 | 255 555 ( 1,21 % ) | 34 755 $ | 31/08/2026 |
Postes actifs de Jeffrey Bacha
| Sociétés | Poste | Début |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Président | 01/12/2020 |
Leukemia & Lymphoma Society Greater San Francisco Bay Area | Directeur/Membre du Conseil | 01/10/2018 |
National Brain Tumor Society, Inc.
 National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a foundation focused on brain tumors | Corporate Officer/Principal | - |
NewGen Therapeutics, Inc.
 NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provide research and development services | Directeur Général | - |
Edison Oncology Holding Corp.
 Edison Oncology Holding Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for anti tumors | Fondateur | 01/01/2018 |
Del Mar Pharmaceuticals (BC) Ltd.
 Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Fondateur | 18/10/2010 |
Anciens postes connus de Jeffrey Bacha
| Sociétés | Poste | Fin |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Directeur/Membre du Conseil | 01/01/2022 |
| KINTARA THERAPEUTICS, INC. | Directeur Général | 07/11/2017 |
| TERRAVOLT HOLDINGS, INC. | Directeur/Membre du Conseil | 14/12/2009 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Bacha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
EACOM Timber Corp.
 EACOM Timber Corp. Forest ProductsNon-Energy Minerals Engages in manufacturing, marketing and distribution of lumber and wood-based value-added products | Non-Energy Minerals |
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes innate defense regulators | Health Technology |
Kintara Therapeutics, Inc.
 Kintara Therapeutics, Inc. BiotechnologyHealth Technology Develops novel cancer therapies | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clerac LLC
 Clerac LLC Finance/Rental/LeasingFinance Provides car rental services | Finance |
CalEthos, Inc.
 CalEthos, Inc. Engineering & ConstructionIndustrial Services Develops and builds data center infrastructure | Industrial Services |
Leukemia & Lymphoma Society Greater San Francisco Bay Area | |
KPMG Health Ventures | |
Covenant House Vancouver
 Covenant House Vancouver Services to the Health IndustryHealth Services Provides community support services to street youth | Health Services |
XBiotech USA, Inc.
 XBiotech USA, Inc. BiotechnologyHealth Technology Manufactures antibodies | Health Technology |
National Brain Tumor Society, Inc.
National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a foundation focused on brain tumors | Commercial Services |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Del Mar Pharmaceuticals (BC) Ltd.
Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Urigen Holdings, Inc. | |
Clera Inc.
 Clera Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Commercial Services |
Edison Oncology Holding Corp.
Edison Oncology Holding Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for anti tumors | Health Technology |
NewGen Therapeutics, Inc.
NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provide research and development services | Health Technology |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
AD4 Capital Corp.
 AD4 Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
